Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis

Toxicology Letters
B G Lake

Abstract

A wide variety of chemicals have been shown to produce liver enlargement, peroxisome proliferation and induction of peroxisomal and microsomal fatty acid-oxidising enzyme activities in rats and mice. Some peroxisome proliferators have also been shown to increase the incidence of liver tumours in these species. Rodent peroxisome proliferators are not considered to be genotoxic agents. Proposed mechanisms of liver tumour formation include induction of sustained oxidative stress, enhanced cell replication, promotion of spontaneous preneoplastic lesions and inhibition of apoptosis. Marked species differences in the effects of peroxisome proliferators have been observed in both in vitro and in vivo studies. Key issues concerning the risk assessment to humans of exposure to rodent peroxisome proliferators are discussed.

References

Feb 1, 1991·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·D E MoodyD H Reese
Oct 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G G Gibson
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerR M Evans
May 1, 1994·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J H Weisburger
Jan 1, 1994·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·M J GrahamF W Bonner
Feb 1, 1994·Journal of Pharmacological and Toxicological Methods·P S Foxworthy, P I Eacho
Nov 1, 1993·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P BentleyH J Wiegand

❮ Previous
Next ❯

Citations

Feb 14, 2002·Biochemical Pharmacology·Arnaud BianchiMichel Dauça
Nov 24, 1999·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P A JonesR U Pendlington
Jul 1, 2002·Environmental Toxicology and Pharmacology·Brian G LakeRoger J Price
May 12, 2000·Environmental Health Perspectives·L H LashC S Scott
Oct 18, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Marco Fidaleo
Feb 18, 2011·Fundamental & Clinical Pharmacology·Chandrashekar NaveenkumarThiruvengadam Devaki
Nov 14, 1997·Regulatory Toxicology and Pharmacology : RTP·T J FlammangP P Fu
Jul 13, 2000·Human & Experimental Toxicology·V GollL Richert
Jun 30, 2010·Toxicologic Pathology·Robert R MaronpotJerrold M Ward
Jan 20, 2004·Critical Reviews in Toxicology·James E KlaunigPenelope A Fenner-Crisp
Jul 2, 1999·Regulatory Toxicology and Pharmacology : RTP·J DoullM van Gemert
Feb 5, 2004·Archives of Biochemistry and Biophysics·Xinlian ChenArlan Richardson
Dec 13, 2005·Cancer Treatment Reviews·Tong Wu
Aug 3, 2021·Journal of Toxicology·S Simar-MentièresA Chentouf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.